Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the page's metadata or rendering without altering core content.
    Difference
    0.0%
    Check dated 2026-06-05T13:16:46.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The Record History section now reflects a newer revision (v3.5.4) and no longer shows v3.5.3, indicating a page update to the version label.
    Difference
    0.0%
    Check dated 2026-05-15T05:22:36.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s software/UI revision label is updated from `v3.5.2` to `v3.5.3`, indicating a minor technical release of the ClinicalTrials.gov interface rather than a modification to the underlying study record.
    Difference
    0.0%
    Check dated 2026-04-24T05:58:58.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history.
    Difference
    0.0%
    Check dated 2026-04-17T02:44:07.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:25:27.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added to the page. Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:20:40.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.